ImpediMed Ltd
ASX:IPD
ImpediMed Ltd
ASX:IPD
Price:
0.079 AUD
1.28%
Market Closed
Updated:
May 30, 2024
ImpediMed Ltd
Cash from Financing Activities
|
ImpediMed Ltd
Cash from Financing Activities Peer Comparison
Comparables:
NTI
C
CYC
COH
OIL
EMV
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
ImpediMed Ltd
ASX:IPD
|
Cash from Financing Activities
AU$28m
|
CAGR 3-Years
3%
|
CAGR 5-Years
192%
|
CAGR 10-Years
N/A
|
|
|
Neurotech International Ltd
ASX:NTI
|
Cash from Financing Activities
AU$9.4m
|
CAGR 3-Years
47%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Cash from Financing Activities
-AU$1m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
2%
|
|
|
Cochlear Ltd
ASX:COH
|
Cash from Financing Activities
-AU$377.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-21%
|
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Cash from Financing Activities
AU$16.2m
|
CAGR 3-Years
21%
|
CAGR 5-Years
140%
|
CAGR 10-Years
54%
|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Cash from Financing Activities
AU$2.5m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
See Also
What is ImpediMed Ltd's Cash from Financing Activities?
Cash from Financing Activities
28m
AUD
28m
AUD
Based on the financial report for Dec 31, 2023, ImpediMed Ltd's Cash from Financing Activities amounts to 28m AUD.
What is ImpediMed Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
192%
192%
The average annual Cash from Financing Activities growth rates for ImpediMed Ltd have been 3% over the past three years , 192% over the past five years .
You don't have any saved screeners yet
